XML 23 R73.htm IDEA: XBRL DOCUMENT v3.2.0.727
Stock-Based Compensation Plans - Additional Information 2 (Detail) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Mar. 31, 2014
Jun. 30, 2015
Jun. 30, 2014
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Stock-based compensation expense $ 18,411 $ 24,985   $ 32,902 $ 39,122
Performance Shares          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Stock-based compensation expense       $ 4,100 $ 4,700
Units granted [1]       276,204  
Weighted average grant date fair value       $ 56.78 [1] $ 86.14
Vesting period     3 years 3 years  
Equity Awards          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Stock-based compensation expense       $ 14,000 $ 14,700
Units granted       583,011 355,000
Weighted average grant date fair value       $ 52.45 $ 84.96
Vesting period       3 years  
Restricted Stock Liability Awards          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Stock-based compensation expense       $ 11,700 $ 15,200
Units granted       332,588  
Weighted average grant date fair value       $ 56.45  
Restricted Stock Liability Awards | Employees          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Units granted       294,000 207,000
Weighted average grant date fair value       $ 56.20 $ 87.27
Vesting period       3 years 3 years
Restricted Stock Liability Awards | Non Employee Director          
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]          
Units granted       39,000 61,000
Weighted average grant date fair value       $ 58.35 $ 88.47
[1] Amounts granted reflect the number of performance units granted; however, the actual payout of shares will be between zero percent and 150% of the performance units granted depending on the total shareholder return ranking compared to the peer companies at the end of the three-year performance period.